|
Volumn 22, Issue 6, 2005, Pages 543-545
|
Atypical pyoderma gangrenosum as a manifestation of childhood acute lymphoblastic leukemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACUTE LYMPHOBLASTIC LEUKEMIA;
ARTICLE;
CASE REPORT;
CHILDHOOD LEUKEMIA;
CLINICAL FEATURE;
DISEASE ASSOCIATION;
HUMAN;
HUMAN TISSUE;
IDIOPATHIC DISEASE;
LYMPHOCYTIC INFILTRATION;
MALE;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
PYODERMA GANGRENOSUM;
SKIN BIOPSY;
SKIN INFILTRATE;
SYSTEMIC DISEASE;
ACUTE LYMPHOCYTIC LEUKEMIA;
DIFFERENTIAL DIAGNOSIS;
FOLLOW UP;
HOSPITALIZATION;
IMMUNOHISTOCHEMISTRY;
NEEDLE BIOPSY;
PATHOLOGY;
RISK ASSESSMENT;
TREATMENT OUTCOME;
ANTIINFECTIVE AGENT;
ANTINEOPLASTIC AGENT;
ASPARAGINASE;
DAUNORUBICIN;
PREDNISONE;
VINCRISTINE;
ANTI-BACTERIAL AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASPARAGINASE;
BIOPSY, NEEDLE;
CHILD, PRESCHOOL;
DAUNORUBICIN;
DIAGNOSIS, DIFFERENTIAL;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
MALE;
PREDNISONE;
PYODERMA GANGRENOSUM;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 33644812136
PISSN: 07368046
EISSN: 15251470
Source Type: Journal
DOI: 10.1111/j.1525-1470.2005.00136.x Document Type: Article |
Times cited : (14)
|
References (10)
|